Clinical Trial Update: A Study of the Effect of Food on the Pharmacokinetics of Single Dose RO5185426 And the Safety And Efficacy of Continuous Administration in Patients With BRAF V600E Mutation-Positive Metastatic Melanoma [Phase 1]

View source ↗

Summary

The trial investigated how food affects the pharmacokinetics of a single dose of RO5185426 and evaluated the safety and efficacy of continuous administration in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• RO5185426

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Malignant Melanoma | Phase 1 | Status: COMPLETED | Results posted: 2015-12-17